SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-224115
Filing Date
2022-08-18
Accepted
2022-08-18 16:10:58
Documents
18
Period of Report
2022-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d280175d8k.htm   iXBRL 8-K 32619
2 EX-1.1 d280175dex11.htm EX-1.1 157380
3 EX-4.2 d280175dex42.htm EX-4.2 176343
4 EX-5.1 d280175dex51.htm EX-5.1 21178
9 GRAPHIC g280175g32f82.jpg GRAPHIC 8995
10 GRAPHIC g280175g89i30.jpg GRAPHIC 12372
  Complete submission text file 0001193125-22-224115.txt   652768

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA amgn-20220815.xsd EX-101.SCH 3909
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20220815_def.xml EX-101.DEF 13283
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20220815_lab.xml EX-101.LAB 21865
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20220815_pre.xml EX-101.PRE 14180
12 EXTRACTED XBRL INSTANCE DOCUMENT d280175d8k_htm.xml XML 5150
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 221177610
SIC: 2836 Biological Products, (No Diagnostic Substances)